vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and National Energy Services Reunited Corp. (NESR). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $295.3M, roughly 1.7× National Energy Services Reunited Corp.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 6.0%, a 0.8% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -12.2%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

National Energy Services Reunited Corp. is a leading integrated oilfield services provider offering a full suite of solutions covering well construction, completion, production, and intervention services for upstream oil and gas operators. Its core markets cover the Middle East, North Africa, and East Asia, serving both national oil companies and international energy clients.

MD vs NESR — Head-to-Head

Bigger by revenue
MD
MD
1.7× larger
MD
$493.8M
$295.3M
NESR
Growing faster (revenue YoY)
MD
MD
+10.5% gap
MD
-1.7%
-12.2%
NESR
Higher net margin
MD
MD
0.8% more per $
MD
6.8%
6.0%
NESR

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MD
MD
NESR
NESR
Revenue
$493.8M
$295.3M
Net Profit
$33.7M
$17.7M
Gross Margin
12.0%
Operating Margin
9.9%
6.6%
Net Margin
6.8%
6.0%
Revenue YoY
-1.7%
-12.2%
Net Profit YoY
10.5%
-14.0%
EPS (diluted)
$0.40
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
NESR
NESR
Q4 25
$493.8M
Q3 25
$492.9M
$295.3M
Q2 25
$468.8M
$327.4M
Q1 25
$458.4M
$303.1M
Q4 24
$502.4M
Q3 24
$511.2M
$336.2M
Q2 24
$504.3M
$325.0M
Q1 24
$495.1M
Net Profit
MD
MD
NESR
NESR
Q4 25
$33.7M
Q3 25
$71.7M
$17.7M
Q2 25
$39.3M
$15.2M
Q1 25
$20.7M
$10.4M
Q4 24
$30.5M
Q3 24
$19.4M
$20.6M
Q2 24
$-153.0M
$18.9M
Q1 24
$4.0M
Gross Margin
MD
MD
NESR
NESR
Q4 25
Q3 25
12.0%
Q2 25
13.4%
Q1 25
12.4%
Q4 24
Q3 24
15.9%
Q2 24
16.4%
Q1 24
Operating Margin
MD
MD
NESR
NESR
Q4 25
9.9%
Q3 25
13.8%
6.6%
Q2 25
12.8%
8.3%
Q1 25
7.0%
6.9%
Q4 24
7.8%
Q3 24
6.6%
10.5%
Q2 24
-31.3%
10.5%
Q1 24
3.2%
Net Margin
MD
MD
NESR
NESR
Q4 25
6.8%
Q3 25
14.5%
6.0%
Q2 25
8.4%
4.6%
Q1 25
4.5%
3.4%
Q4 24
6.1%
Q3 24
3.8%
6.1%
Q2 24
-30.3%
5.8%
Q1 24
0.8%
EPS (diluted)
MD
MD
NESR
NESR
Q4 25
$0.40
Q3 25
$0.84
$0.18
Q2 25
$0.46
$0.16
Q1 25
$0.24
$0.11
Q4 24
$0.37
Q3 24
$0.23
$0.22
Q2 24
$-1.84
$0.20
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
NESR
NESR
Cash + ST InvestmentsLiquidity on hand
$375.2M
$69.7M
Total DebtLower is stronger
$570.5M
$274.1M
Stockholders' EquityBook value
$865.9M
$956.7M
Total Assets
$2.2B
$1.8B
Debt / EquityLower = less leverage
0.66×
0.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
NESR
NESR
Q4 25
$375.2M
Q3 25
$340.1M
$69.7M
Q2 25
$224.7M
$131.8M
Q1 25
$99.0M
$78.7M
Q4 24
$229.9M
Q3 24
$103.8M
$118.2M
Q2 24
$19.4M
$75.0M
Q1 24
$8.0M
Total Debt
MD
MD
NESR
NESR
Q4 25
$570.5M
Q3 25
$577.2M
$274.1M
Q2 25
$583.9M
$291.7M
Q1 25
$590.5M
$309.2M
Q4 24
$597.1M
Q3 24
$358.7M
Q2 24
$376.7M
Q1 24
Stockholders' Equity
MD
MD
NESR
NESR
Q4 25
$865.9M
Q3 25
$890.7M
$956.7M
Q2 25
$833.8M
$936.9M
Q1 25
$789.2M
$920.5M
Q4 24
$764.9M
Q3 24
$732.5M
$873.5M
Q2 24
$706.5M
$851.4M
Q1 24
$856.2M
Total Assets
MD
MD
NESR
NESR
Q4 25
$2.2B
Q3 25
$2.2B
$1.8B
Q2 25
$2.1B
$1.8B
Q1 25
$2.0B
$1.8B
Q4 24
$2.2B
Q3 24
$2.1B
$1.8B
Q2 24
$2.0B
$1.8B
Q1 24
$2.2B
Debt / Equity
MD
MD
NESR
NESR
Q4 25
0.66×
Q3 25
0.65×
0.29×
Q2 25
0.70×
0.31×
Q1 25
0.75×
0.34×
Q4 24
0.78×
Q3 24
0.41×
Q2 24
0.44×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
NESR
NESR
Operating Cash FlowLast quarter
$114.1M
$6.7M
Free Cash FlowOCF − Capex
$-34.1M
FCF MarginFCF / Revenue
-11.5%
Capex IntensityCapex / Revenue
13.8%
Cash ConversionOCF / Net Profit
3.39×
0.38×
TTM Free Cash FlowTrailing 4 quarters
$68.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
NESR
NESR
Q4 25
$114.1M
Q3 25
$137.3M
$6.7M
Q2 25
$137.2M
$98.5M
Q1 25
$-117.5M
$20.5M
Q4 24
$133.0M
Q3 24
$91.8M
$70.8M
Q2 24
$107.0M
Q1 24
$-125.2M
Free Cash Flow
MD
MD
NESR
NESR
Q4 25
Q3 25
$-34.1M
Q2 25
$68.7M
Q1 25
$-9.6M
Q4 24
Q3 24
$43.4M
Q2 24
Q1 24
FCF Margin
MD
MD
NESR
NESR
Q4 25
Q3 25
-11.5%
Q2 25
21.0%
Q1 25
-3.2%
Q4 24
Q3 24
12.9%
Q2 24
Q1 24
Capex Intensity
MD
MD
NESR
NESR
Q4 25
Q3 25
13.8%
Q2 25
9.1%
Q1 25
9.9%
Q4 24
Q3 24
8.1%
Q2 24
Q1 24
Cash Conversion
MD
MD
NESR
NESR
Q4 25
3.39×
Q3 25
1.91×
0.38×
Q2 25
3.49×
6.48×
Q1 25
-5.66×
1.97×
Q4 24
4.36×
Q3 24
4.72×
3.43×
Q2 24
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

NESR
NESR

Production Services$174.4M59%
Drilling And Evaluation Services$120.9M41%

Related Comparisons